Department of Otolaryngology

Medicine & Life Sciences

1. Allergic Rhinitis 19%
2. Annexins 10%
3. Apoptosis 9%
4. Audiometry 10%
5. Autophagy 10%
6. Bell Palsy 11%
7. Bone Conduction 10%
8. Carcinoma 13%
9. Case-Control Studies 25%
10. Child 24%
11. Cholesteatoma 16%
12. Clear-cell metastatic renal cell carcinoma 12%
13. Cochlear Implants 43%
14. Cohort Studies 42%
15. Comorbidity 13%
16. Confidence Intervals 27%
17. Coronary Disease 9%
18. Databases 33%
19. Down-Regulation 12%
20. Ear Canal 17%
21. Electric Stimulation 11%
22. Facial Nerve 10%
23. Foreign Bodies 13%
24. Guinea Pigs 10%
25. Head 13%
26. Head and Neck Neoplasms 20%
27. Health Insurance 22%
28. Hearing 21%
29. Hearing Loss 20%
30. hesperetin 14%
31. hesperetin-7,3'-O-dimethylether 10%
32. Histiocytic Necrotizing Lymphadenitis 12%
33. Hydroxymethylglutaryl-CoA Reductase Inhibitors 23%
34. Incidence 22%
35. Iron-Deficiency Anemias 9%
36. Ketamine 11%
37. Laser Lithotripsy 10%
38. Logistic Models 16%
39. Mechanistic Target of Rapamycin Complex 1 11%
40. Medicine 9%
41. Mouth Neoplasms 18%
42. Myringoplasty 29%
43. Nasal Obstruction 9%
44. Nasopharyngeal Carcinoma 50%
45. Nasopharyngeal Neoplasms 14%
46. National Health Programs 11%
47. Neck 27%
48. Neoplasm Metastasis 15%
49. Neoplasms 23%
50. Nose 36%
51. Obstructive Sleep Apnea 24%
52. Odds Ratio 21%
53. Otitis Media 16%
54. Otolaryngology 23%
55. Ovalbumin 22%
56. ovatodiolide 16%
57. Parotid Gland 11%
58. Pediatrics 11%
59. Phosphodiesterase 4 Inhibitors 11%
60. Phosphoric Diester Hydrolases 9%
61. poly(lactide) 15%
62. Population 62%
63. Radiotherapy 18%
64. Retinal Vein Occlusion 10%
65. Retrospective Studies 12%
66. Rolipram 13%
67. Salivary Ducts 13%
68. Salivary Gland Calculi 44%
69. Salivary Glands 13%
70. Sensorineural Hearing Loss 82%
71. Sialadenitis 14%
72. Sinusitis 12%
73. Smartphone 14%
74. Smooth Muscle 13%
75. Solid-State Lasers 13%
76. Squamous Cell Carcinoma 12%
77. Squamous Cell Carcinoma of Head and Neck 17%
78. Submandibular Gland 11%
79. Sudden Hearing Loss 95%
80. Survival 19%
81. Systemic Lupus Erythematosus 11%
82. Taiwan 100%
83. Temozolomide 9%
84. Temperature 14%
85. Tension-Type Headache 10%
86. Therapeutics 14%
87. Tissue Engineering 13%
88. Tongue 11%
89. Tonsillectomy 9%
90. Trachea 27%
91. Transplants 11%
92. Triple Negative Breast Neoplasms 9%
93. Tympanic Membrane Perforation 12%
94. Tympanoplasty 21%
95. Type 4 Cyclic Nucleotide Phosphodiesterase 12%
96. Up-Regulation 10%
97. Vocal Cords 10%
98. Xylazine 14%
99. Zinc 11%